| Date Filed | Type | Description |
| 10/12/2023 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 10/03/2023 |
4
| Kadia Siddhartha (CEO) has filed a Form 4 on Bruker Cellular Analysis, Inc.|
Txns:
| Disposed/sold 595,395 shares
@ $0
Disposed/sold 645,294 shares
@ $0 |
|
| 10/03/2023 |
4
| Chiminski John R (Director) has filed a Form 4 on Bruker Cellular Analysis, Inc.|
Txns:
| Disposed/sold 71,225 shares
@ $0
Disposed/sold 41,240 shares
@ $0 |
|
| 10/03/2023 |
4
| Silvester Peter (Director) has filed a Form 4 on Bruker Cellular Analysis, Inc.|
Txns:
| Exercised 140,000 shares
@ $0
Disposed/sold 64,596 shares
@ $0 |
|
| 10/03/2023 |
4
| Hopfield Jessica (Director) has filed a Form 4 on Bruker Cellular Analysis, Inc.|
Txns:
| Exercised 74,030 shares
@ $0
Disposed/sold 105,207 shares
@ $0 |
|
| 10/03/2023 |
4
| Joshi Mehul (CFO) has filed a Form 4 on Bruker Cellular Analysis, Inc.|
Txns:
| Exercised 775,517 shares
@ $0
Disposed/sold 65,013 shares
@ $0 |
|
| 10/03/2023 |
4
| Hobbs Eric (VP, Global Operations) has filed a Form 4 on Bruker Cellular Analysis, Inc.|
Txns:
| Exercised 205,363 shares
@ $0
Disposed/sold 244,816 shares
@ $0 |
|
| 10/03/2023 |
4
| MORITZ MICHAEL J (Director) has filed a Form 4 on Bruker Cellular Analysis, Inc.|
Txns:
| Exercised 70,000 shares
@ $0
Disposed/sold 174,662 shares
@ $0
Disposed/sold 755,670 shares
@ $0
Disposed/sold 47,432 shares
@ $0
Disposed/sold 279,214 shares
@ $0
Disposed/sold 6,035 shares
@ $0
Disposed/sold 16,805 shares
@ $0
Disposed/sold 61,325 shares
@ $0
Disposed/sold 110,782 shares
@ $0 |
|
| 10/03/2023 |
4
| LUCIER GREGORY T (Director) has filed a Form 4 on Bruker Cellular Analysis, Inc.|
Txns:
| Exercised 70,000 shares
@ $0
Disposed/sold 136,062 shares
@ $0 |
|
| 10/03/2023 |
4
| NELSON ELIZABETH A (Director) has filed a Form 4 on Bruker Cellular Analysis, Inc.|
Txns:
| Exercised 70,000 shares
@ $0
Disposed/sold 75,965 shares
@ $0 |
|
| 10/03/2023 |
4
| Rothman James (Director) has filed a Form 4 on Bruker Cellular Analysis, Inc.|
Txns:
| Disposed/sold 118,810 shares
@ $0 |
|
| 10/03/2023 |
4
| KHANDROS IGOR Y (Director) has filed a Form 4 on Bruker Cellular Analysis, Inc.|
Txns:
| Exercised 70,000 shares
@ $0
Disposed/sold 8,819,993 shares
@ $0 |
|
| 10/03/2023 |
4
| BRUKER CORP (10% Owner) has filed a Form 4 on Bruker Cellular Analysis, Inc.|
Txns:
| Acquired 1,000 shares
@ $99711.327, valued at
$99.7M
|
|
| 10/03/2023 |
3
| BRUKER CORP (10% Owner) has filed a Form 3 on Bruker Cellular Analysis, Inc. |
| 10/02/2023 |
POSASR
| Form POSASR - Post-effective Amendment to an automatic shelf registration statement: |
| 10/02/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 10/02/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 10/02/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 10/02/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 10/02/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 10/02/2023 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 10/02/2023 |
8-K
| Quarterly results |
| 09/29/2023 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 09/29/2023 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 08/18/2023 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer: |
| 08/17/2023 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer: |
| 08/17/2023 |
8-K
| Quarterly results |
| 08/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/17/2023 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 08/17/2023 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer: |
| 08/17/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 08/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/14/2023 |
8-K
| Quarterly results |
|